摘要
目的探讨槲皮素对非酒精性脂肪性肝炎(NASH)模型大鼠的干预作用及对大鼠肝组织中脂联素、脂联素受体的影响。方法按照体重将雄性SD大鼠随机分为4组:正常组、模型组和低、高2个剂量实验组,每组9只。正常组予普通饲料,其余各组予高脂饲料10周建模。造模第2周,低、高2个剂量实验组灌胃40,80 mg·kg^-1·d^-1槲皮素(用1%羧甲基纤维素钠助溶);正常组和模型组灌胃等体积1%羧甲基纤维素钠。以化学发光法检测各组大鼠谷丙转氨酶(GPT)、谷草转氨酶(GOT)、碱性磷酸酶(ALP)、谷氨酰转肽酶(GGT)、三酰甘油(TG)和总胆固醇(TC)水平,以免疫印迹法检测各组大鼠肝内脂联素(ADPN)、脂联素受体2(Adipo R2)蛋白表达水平,以荧光定量PCR检测各组大鼠肝内ADPN、Adipo R2 m RNA表达水平。结果正常组、模型组和低、高2个剂量实验组的GPT分别为(43.51±1.52),(81.60±3.49),(69.15±2.78)和(53.98±2.01)U·L^-1;上述4组的GOT分别为(216.46±11.79),(302.30±29.34),(225.32±11.28)和(215.07±15.69)U·L^-1;上述这4组的ALP分别为(88.58±3.92),(176.63±11.72),(138.88±8.34)和(119.17±17.36)U·L^-1;上述这4组的GGT分别为(0.42±0.09),(1.43±0.17),(1.12±0.17)和(0.88±0.12)U·L^-1;上述这4组的TG分别为(0.16±0.02),(0.47±0.09),(0.43±0.08)和(0.23±0.06)mmol·L^-1;上述这4组的TC分别为(0.93±0.04),(1.72±0.09),(1.60±0.18)和(1.45±0.15)mmol·L^-1。上述指标:模型组与正常组相比、或者高剂量实验组与模型组相比,差异均有统计学意义(均P<0.05)。正常组、模型组和低、高2个剂量实验组的ADPN蛋白表达水平(OD值)分别为0.73±0.05,0.24±0.01,0.33±0.14和0.58±0.07;上述这4组的Adipo R2蛋白表达水平(OD值)分别为0.91±0.06,0.30±0.02,0.45±0.11和0.88±0.15;高剂量实验组与模型组比较,肝组织ADPN和Adipo R2蛋白水平均明显升高,差异均有统计学意义(均P<0.05);基因结果的趋势与蛋白一致。结论槲皮素能通过上调NASH模型大鼠ADPN、Adipo R2表达,有效改善肝功能、血脂,改善NASH大鼠肝组织脂肪变程度,减轻肝炎症。
Objective To investigate the effects of quercetin on nonalcoholic steatohepatitis(NASH)model rats and the effects of quercetin on adiponectin and adiponectin receptors on rat liver tissue.Methods The male Sprague-Dawley rats were randomly divided into 4 groups:normal group,model group,and experimental-L,experimental-H groups,with 9 rats in each group.The normal group was given normal feed,and the other groups were modeled for high fat feed for a total of 10 weeks.In the second week of moulding,quercetin 40,80 mg·kg^-1·d^-1 was administered intragastrically in low and high dose experimental groups(solubilization with 1%sodium carboxymethyl cellulos);1%sodium carboxymethyl cellulos was administered intragastrically in normal group,model group.Glutamic-pyruvic transaminase(GPT),glutamic-oxaloacetic transaminase(GOT),alkaline phosphatase(ALP),glutamyl transpeptidase(GGT),triglyceride(TG)and cholesterol(TC)were detected by chemiluminescence method.Western-blot was used to detect the protein expression levels of Adiponectin(ADPN)and Adiponectin receptor 2(AdipoR2)in the liver of each group.ADPN,AdipoR2 m RNA expression level in rats was was detected by fluorescence quantitative real-time PCR.Results The GPT in normal group,model group,experimental-L group,experimental-H group respectively were(43.51±1.52),(81.60±3.49),(69.15±2.78)and(53.98±2.01)U·L^-1;GOT in the above 4 groups respectively were(216.46±11.79),(302.30±29.34),(225.32±11.28)and(215.07±15.69)U·L^-1;ALP in the above 4 groups respectively were(88.58±3.92),(176.63±11.72),(138.88±8.34)and(119.17±17.36)U·L^-1;GGT in the above 4 groups respectively were(0.42±0.09),(1.43±0.17),(1.12±0.17)and(0.88±0.12)U·L^-1;TG in the above 4 groups respectively were(0.16±0.02),(0.47±0.09),(0.43±0.08)and(0.23±0.06)mmol·L^-1;TC in the above 4 groups respectively were(0.93±0.04),(1.72±0.09),(1.60±0.18)and(1.45±0.15)mmol·L^-1;comparing between model group and normal group,or experimental-H group and model group,the difference of the factors were significant(all P<0.05).The protein expression(OD value)of ADPN in normal group,model group,experimental-L group,experimental-H group respectively were 0.73±0.05,0.24±0.01,0.33±0.14 and 0.58±0.07;and protein expression(OD value)of AdipoR2 in the above 4 groups respectively were 0.91±0.06,0.30±0.02,0.45±0.11 and 0.88±0.15;comparing between experimental-H group and model group,the levels of ADPN and AdipoR2 protein in the liver tissue of experimental-H group were increased,the difference of the factors were significant(all P<0.05).The trend of gene results is consistent with that of protein.Conclusion Quercetin can up-regulate the expression of ADPN and AdipoR2 in NASH model rats,effectively improve liver function and blood lipids,improve the degree of hepatic steatosis in NASH rats,and reduce liver inflammation.
作者
刘鸣昊
张丽慧
马庆亮
赵文霞
LIU Ming-hao;ZHANG Li-hui;MA Qing-liang;ZHAO Wen-xia(Department of Gastroenterology,The First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450008,Henan Province,China)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2019年第20期2597-2601,共5页
The Chinese Journal of Clinical Pharmacology
基金
国家自然科学基金资助项目(81473651)
河南省高等学校青年骨干教师培养计划基金资助项目(2017GGJS083)
河南省科技攻关计划基金资助项目(192102310425)
河南省中医药科学研究专项课题基金资助项目(2018JDZX072)
河南中医药大学“博士科研基金”资助项目(BSJJ2014-19)